(Q44530574)

English

Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model.

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

Nikolai G. Rainov

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Constanze Nafe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Yong-Jiang Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Ariel Quinones

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Karl-Ulrich Dobberstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Christof M Kramm

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

73

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1847-1860

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888123%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

The three-dimensional solution structure and dynamic properties of the human FADD death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

THP-1 monocytic leukemia cells express Fas ligand constitutively and kill Fas-positive Jurkat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Inhibition of Fas-induced apoptosis by Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Gene therapy for brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Non-cleavable mutant Fas ligand transfection of donor cornea abrogates ocular immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Flow cytometry analysis of the Fas ligand expression of activated lymph node T-cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Adenovirus-mediated transfer of p53 and Fas ligand drastically enhances apoptosis in gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Cell death induced by the Fas/Fas ligand pathway and its role in pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

CD95 ligand: lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900542-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44530574&oldid=2127854086"